tirzepatide chemical structure (LY3298176) sodium | GIP/GLP-1 Receptor Agonist | CAS 2023788-19-2 (free base) File:Tirzepatide structure.svg - Wikimedia Commons

This performance puts it ahead of both single and dual agonist options

Whether youre exploring Ozempic for diabetes management, Wegovy for weight loss, or other semaglutide options, taking time to understand your full range of affordable options ensures you can make the healthcare decision thats right for your needs and budget

Approved in April 2026, this orforglipron-based pill offers flexibility, needing no food or water restrictions, and boasting an average weight loss of 12.4%

[DOI] [PubMed] [Google Scholar] 113.Hodges D.M., Forney C

Dosing & Reconstitution Guide Educational guide for reconstitution and common dosing patterns Standard / Conservative Approach (3 mL = 33.33 mg/mL